OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 116 filers reported holding OCULAR THERAPEUTIX INC in Q4 2022. The put-call ratio across all filers is 0.82 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $215,969 | +599.1% | 68,780 | +1048.8% | 0.00% | – |
| Q2 2023 | $30,893 | -38.3% | 5,987 | -37.0% | 0.00% | – |
| Q1 2023 | $50,076 | +591.8% | 9,502 | +268.9% | 0.00% | – |
| Q4 2022 | $7,239 | -65.5% | 2,576 | -48.8% | 0.00% | – |
| Q3 2022 | $21,000 | +50.0% | 5,035 | +47.7% | 0.00% | – |
| Q2 2022 | $14,000 | +27.3% | 3,409 | +59.4% | 0.00% | – |
| Q1 2022 | $11,000 | -99.9% | 2,138 | -99.8% | 0.00% | -100.0% |
| Q3 2021 | $11,353,000 | -33.2% | 1,135,345 | -5.3% | 0.00% | 0.0% |
| Q2 2021 | $17,001,000 | +460.5% | 1,198,937 | +548.5% | 0.00% | – |
| Q1 2021 | $3,033,000 | -20.7% | 184,868 | -0.0% | 0.00% | – |
| Q4 2020 | $3,826,000 | +1052.4% | 184,874 | +323.5% | 0.00% | – |
| Q3 2020 | $332,000 | -76.1% | 43,653 | -73.8% | 0.00% | – |
| Q2 2020 | $1,387,000 | +68.3% | 166,453 | 0.0% | 0.00% | – |
| Q1 2020 | $824,000 | +25.4% | 166,453 | 0.0% | 0.00% | – |
| Q4 2019 | $657,000 | -24.2% | 166,453 | -41.6% | 0.00% | – |
| Q3 2019 | $867,000 | -71.4% | 285,053 | -58.6% | 0.00% | – |
| Q2 2019 | $3,030,000 | -58.5% | 688,648 | -62.6% | 0.00% | -100.0% |
| Q1 2019 | $7,306,000 | -9.7% | 1,840,299 | -9.5% | 0.00% | 0.0% |
| Q4 2018 | $8,094,000 | -48.9% | 2,033,599 | -11.6% | 0.00% | -50.0% |
| Q3 2018 | $15,827,000 | -27.6% | 2,300,399 | -29.0% | 0.00% | -33.3% |
| Q2 2018 | $21,866,000 | +3.7% | 3,239,448 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $21,089,000 | +307.0% | 3,239,448 | +178.2% | 0.00% | +200.0% |
| Q4 2017 | $5,182,000 | -34.6% | 1,164,499 | -9.2% | 0.00% | 0.0% |
| Q3 2017 | $7,922,000 | -35.5% | 1,281,799 | -3.2% | 0.00% | -50.0% |
| Q2 2017 | $12,276,000 | -3.1% | 1,324,299 | -3.0% | 0.00% | 0.0% |
| Q1 2017 | $12,674,000 | -42.2% | 1,365,699 | -47.9% | 0.00% | -33.3% |
| Q4 2016 | $21,936,000 | -9.2% | 2,620,768 | -25.4% | 0.00% | 0.0% |
| Q3 2016 | $24,148,000 | +31.4% | 3,514,930 | -5.3% | 0.00% | 0.0% |
| Q2 2016 | $18,372,000 | -40.2% | 3,711,552 | +16.7% | 0.00% | -25.0% |
| Q1 2016 | $30,715,000 | -11.6% | 3,179,557 | -14.3% | 0.00% | -20.0% |
| Q4 2015 | $34,764,000 | -17.4% | 3,710,128 | +24.0% | 0.01% | -16.7% |
| Q3 2015 | $42,076,000 | -27.2% | 2,992,627 | +8.9% | 0.01% | -14.3% |
| Q2 2015 | $57,812,000 | +0.5% | 2,749,021 | +100.7% | 0.01% | 0.0% |
| Q1 2015 | $57,510,000 | +778.8% | 1,369,764 | +392.3% | 0.01% | +600.0% |
| Q4 2014 | $6,544,000 | – | 278,252 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,932,607 | $40,643,000 | 15.56% |
| Lamond Capital Partners LLC | 711,533 | $14,964,000 | 15.19% |
| Polaris Venture Management Co. V, L.L.C. | 1,230,009 | $25,867,000 | 11.54% |
| NOTTINGHAM ADVISORS, INC. | 171,985 | $3,617,000 | 0.60% |
| Portolan Capital Management | 122,518 | $2,577,000 | 0.36% |
| SPHERA FUNDS MANAGEMENT LTD. | 160,000 | $3,365,000 | 0.33% |
| Rotella Capital Management, Inc. | 18,461 | $388,000 | 0.32% |
| Monashee Investment Management LLC | 28,834 | $606,000 | 0.29% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 335,498 | $7,056,000 | 0.24% |
| BAILARD, INC. | 55,000 | $1,157,000 | 0.18% |